Heart Health
Indoor Cycling Three Times a Week Targets CVD Risk Factors in Women With Obesity
A 3-month interval cycling program assessed cardiovascular and metabolic improvements in obese vs. normal-weight women.
Ensaio Clínico
27 de mai. de 2026 0
Tema de Pesquisa
Heart Health
Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
619 artigos
Heart Health
Anticoagulation Clinics Show How to Manage Heart Medications Smarter
Experts propose that structured anticoagulation services offer a blueprint for broader cardiovascular medication stewardship programs.
Artigo Científico
27 de mai. de 2026 0
Heart Health
2025 AHA/ACC Hypertension Guidelines Get Official Correction Update
A formal correction is issued to the landmark 2025 multi-society hypertension guidelines, ensuring clinical accuracy for practitioners.
Artigo Científico
27 de mai. de 2026 0
Heart Health
Breast Cancer Treatment Uncovers Hidden BMPR2 Risk for Pulmonary Hypertension
A correction to a landmark study linking breast cancer to latent BMPR2-driven pulmonary hypertension susceptibility in Circulation.
Artigo Científico
27 de mai. de 2026 0
Heart Health
Major Trial Finds Beta Blockers After Heart Attack Offer No Benefit for Most Patients
A landmark 8,500-patient trial challenges 40 years of cardiology practice, finding beta blockers unnecessary after uncomplicated heart attacks.
Comunicado de Imprensa
26 de mai. de 2026 0
Heart Health
Phase 3 Trial Tests Omecamtiv Mecarbil for Reducing Death in Heart Failure Patients
A landmark Phase 3 trial evaluates whether omecamtiv mecarbil, a cardiac myosin activator, reduces cardiovascular death in HFrEF patients.
Ensaio Clínico
26 de mai. de 2026 0
Heart Health
Merck's Niacin-Laropiprant Cholesterol Trial Terminated Before Completion
A phase 3 trial adding ERN/LRPT to statin therapy for dyslipidemia was terminated early, raising questions about the drug's clinical future.
Ensaio Clínico
26 de mai. de 2026 0
Heart Health
Scientists Find Hidden Liver Protein That Slashes Bad Cholesterol
A newly discovered protein called HELZ2 controls how much harmful cholesterol the liver releases, opening a fresh path to heart disease treatment.
Comunicado de Imprensa
25 de mai. de 2026 0
Heart Health
Rare Heart Condition Linked to Glycogen Buildup Reveals New Therapeutic Targets
Scientists uncover how faulty glycogen-priming proteins cause progressive cardiomyopathy, pointing toward gene therapy and autophagy as future treatments.
Artigo Científico
24 de mai. de 2026 0
Heart Health
Eli Lilly Tests Whether Weight-Loss Drug Retatrutide Alters Heart Medication Levels
A Phase 1 trial examines if the triple-agonist GLP-1 drug retatrutide changes how the body processes the beta-blocker metoprolol.
Ensaio Clínico
23 de mai. de 2026 0
Heart Health
NEJM Spotlights Hypertension as a Defining Cardiovascular Risk Factor
A new NEJM perspective examines hypertension's central role in cardiovascular risk, with implications for prevention and clinical management.
Artigo Científico
23 de mai. de 2026 0
Heart Health
Hidden Heart Risk: Microvascular Dysfunction Doubles Cardiac Event Rates
A landmark Lancet registry finds coronary microvascular dysfunction raises major cardiac event risk by 91%, even after treating visible blockages.
Artigo Científico
23 de mai. de 2026 0